About
Sitagliptin/Metformin is a widely prescribed combination medication designed to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, functions by preventing the breakdown of incretin hormones, such as GLP-1 and GIP. This preservation leads to a glucose-dependent increase in insulin synthesis and release from pancreatic beta cells, while simultaneously reducing glucagon secretion from alpha cells. Metformin, a biguanide, complements this action by primarily decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues, thereby increasing glucose uptake and utilization. The synergistic effect of these two agents provides a robust mechanism to lower both fasting and postprandial blood glucose levels, offering a comprehensive and effective strategy for managing hyperglycemia and mitigating the risk of diabetes-related complications.
Uses
- Management of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- Used as an adjunct to diet and exercise.
- When monotherapy with metformin or sitagliptin is insufficient.
Directions For Use
Take orally, usually twice daily with meals to reduce gastrointestinal side effects. Follow your doctor's dosage instructions carefully.
Benefits
- Effectively lowers blood sugar levels.
- Improves both fasting and postprandial glucose.
- Enhances insulin secretion and sensitivity.
- Reduces hepatic glucose production.
- Convenient combination therapy.
- Generally well-tolerated when taken with food.
Side Effects
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Headache
- Upper respiratory tract infection
- Sore throat
- Nasal congestion
- Hypoglycemia (especially with other antidiabetics)
- Pancreatitis (rare)
- Lactic acidosis (rare, with metformin)
- Joint pain
Safety Measures
- Alcohol - Avoid excessive alcohol intake, as it can increase the risk of lactic acidosis with metformin and may cause hypoglycemia.
- Pregnancy - Not recommended during pregnancy. Insulin is generally preferred for glycemic control in pregnant women with diabetes.
- Breastfeeding - Metformin passes into breast milk; sitagliptin's presence is unknown. Use with caution and under medical advice.
- Liver - Use with caution in patients with liver impairment; metformin is contraindicated in severe hepatic dysfunction due to increased lactic acidosis risk.
- Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Dose adjustment needed for moderate impairment.
- Lung - No specific contraindications, but severe respiratory conditions can increase lactic acidosis risk with metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!